SGRY Surgery Partners Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGRY

Price (delayed)

$14.56

Market cap

$1.91B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.69

Enterprise value

$5.71B

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 41
Relative Valuation: Rel. Valuation: 48
Relative Profitability: Rel. Profitability: 45

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care ...

Highlights
The quick ratio rose by 7% QoQ
The revenue has grown by 4% YoY
SGRY's EPS has soared by 52% YoY but it is down by 17% from the previous quarter
The net income has surged by 51% year-on-year but it has declined by 16% since the previous quarter
SGRY's debt is up by 4.7% YoY
The gross margin fell by 5% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.surgerypartners.com
Peers: MD

Key stats

What are the main financial stats of SGRY

SGRY stock price

How has the Surgery Partners stock price performed over time
Intraday
-7.85%
1 week
4.52%
1 month
0.28%
1 year
-33.12%
YTD
-5.76%
QTD
-13.33%

Financial performance

How have Surgery Partners's revenue and profit performed over time
Revenue
$3.37B
Gross profit
$757.9M
Operating income
$362.8M
Net income
-$88.6M
Gross margin
22.5%
Net margin
-2.6%
SGRY's net margin has soared by 54% YoY but it is down by 13% QoQ
The net income has surged by 51% year-on-year but it has declined by 16% since the previous quarter
The operating income has grown by 7% YoY but it has contracted by 2.8% from the previous quarter
The gross margin fell by 5% YoY

Price vs fundamentals

How does SGRY's price correlate with its fundamentals

Growth

What is Surgery Partners's growth rate over time

Valuation

What is Surgery Partners stock price valuation
P/E
N/A
P/B
1.14
P/S
0.56
EV/EBIT
26.76
EV/EBITDA
13.3
EV/Sales
1.7
SGRY's EPS has soared by 52% YoY but it is down by 17% from the previous quarter
The stock's price to book (P/B) is 41% less than its 5-year quarterly average of 2.1 and 4.6% less than its last 4 quarters average of 1.3
The equity has declined by 4.4% year-on-year
The P/S is 50% below the 5-year quarterly average of 1.2
The revenue has grown by 4% YoY

Efficiency

How efficient is Surgery Partners business performance
SGRY's return on assets has surged by 52% year-on-year but it is down by 22% since the previous quarter
Surgery Partners's ROE has increased by 49% YoY but it has decreased by 18% from the previous quarter
SGRY's ROIC is up by 16% YoY but it is down by 2.7% from the previous quarter
SGRY's ROS is up by 15% YoY but it is down by 4.5% from the previous quarter

Dividends

What is SGRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGRY.

Financial health

How did Surgery Partners financials performed over time
The total assets is 63% greater than the total liabilities
The quick ratio rose by 7% QoQ
Surgery Partners's current ratio has increased by 4.8% from the previous quarter
SGRY's debt is 140% higher than its equity
The debt to equity has grown by 9% YoY
SGRY's debt is up by 4.7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.